CORONA

CORONA Remedies Limited

Pharmaceuticals

Share price

₹2,038

Market cap

₹12,462 Cr

1Y return

▲ 42%

Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.

Recent moves 17

Moves17

10 Sept 2026. Sign in to see this move

SBI Mutual FundNew position

SBI Mutual Fund bought 6,80,000 shares of CORONA Remedies Limited for ₹139.40 Cr at ₹2050.00 apiece in a bulk deal.

SBI Mutual FundNew position

SBI Mutual Fund bought 8.6 lakh shares of CORONA Remedies Limited for ₹176.30 Cr at ₹2,050.00 apiece in a bulk deal.

AberdeenNew position

Aberdeen bought 2,74,132 shares of CORONA Remedies Limited for ₹47.42 Cr through a block deal at ₹1730.00 apiece.

AberdeenNew position

Aberdeen purchased 4,50,868 shares of Corona Remedies Limited for ₹78.00 Cr at ₹1730.00 apiece through a block deal.

Invesco Mutual FundNew position

Invesco Mutual Fund took a new position in CORONA Remedies Limited, acquiring 30,92,372 shares, representing a 5.06% stake. The total value of the investment is ₹635.18 Cr based on the share price of ₹2054.10. The fund crossed the 5% disclosure threshold.

HDFC Mutual FundNew position

HDFC Mutual Fund entered Corona Remedies with 25,06,683 shares, acquiring a 4.10% stake worth ₹514.88 Cr at ₹2054.10 apiece. HDFC Mutual Fund was the largest buyer in a June 17, 2026, block deal where Sepia Investments and Anchor Partners sold shares worth approximately ₹777 crore in Corona Remedies.

Invesco Mutual FundIncreased

Invesco Mutual Fund increased its stake in Corona Remedies from 4.58% to 5.06% by purchasing 2,89,017 shares for ₹50 Cr at ₹1730.00 apiece in an open-market transaction, crossing the 5% disclosure threshold.

WhiteOak Capital Mutual FundNew position

WhiteOak Capital Mutual Fund bought 1,45,000 shares of CORONA Remedies Limited for ₹25.09 Cr at ₹1730.00 apiece in a block deal on June 17, 2026.

Kotak Mutual FundNew position

Kotak Mutual Fund bought 1,61,861 shares of CORONA Remedies Limited for ₹28.00 Cr at ₹1730.00 apiece in a block deal.

Track the whales in CORONA Remedies Limited

Get alerted the moment a top investor buys or sells.